Studies suggest that this combination produces greater weight reduction, improved glycemic control, and favorable body composition changes compared to monotherapy
Main Pre-Clinical Research Findings for GW-0742: Main Pre-Clinical Research Findings for GW-0742: Enhances hepatic (liver) fat metabolism [10] Reduces liver stress by improving hepatic energy metabolism [11] Prevents hypertension and vascular inflammation [12] Demonstrates anti-inflammatory effects in lungs [13] Increases cardiac vascularization [14] Prevents neuron cell death following electrolyte imbalance [15] Selected Preclinical Studies: GW0742 (PPAR-beta activator) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice [11] Liver stress and hepatic steatosis are intertwined with insulin resistance
This facial cream is a multi-benefit powerhouse that provides hydration, anti-aging, soothing, and skin-renewing properties
PubMed, doi:10.1016/j.breast.2012.08.004
Together, these compounds theoretically produce additive or synergistic fat loss effects
The vote is non-binding and will still need sign off from the FDA